The bolus is a simple bivalent product ... but then there were these unforeseen events, the syringe shortage in mid-2022, the contamination events, and you could not take that, you could not ...

TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS ...

The prefilled syringe which opens the door for self-administration in the U.S., is expected to be a key driver of this growth in 2025 for both MG and CIDP. It is incredible to see the strong early ...

You mentioned product mix, I totally agree with that. Simply Tri-Shield is more expensive to produce than the bolus. The bolus is a simple bivalent product, a single production train. The Tri ...

ImmuCell Corporation, a small-cap biotech company with a market capitalization of $46.52 million, reported significant sales growth in the fourth quarter of 2024, with revenue reaching $7.8 million.

The published evidence identified also showed that insulin administration via NovoPen ® devices was for most patients easier, more convenient and quicker than with conventional syringes and that ...

ImmuCell Corporation, a small-cap biotech company with a market capitalization of $46.52 million, reported significant sales growth in the fourth quarter of 2024, with revenue reaching $7.8 million.

They instead recommend alternative methods, such as basal-bolus insulin. However, some healthcare professionals may still temporarily use sliding scale insulin therapy for people with noncritical ...

Am J Health Syst Pharm. 2008;65(24):2347-2357. Administer medications via the oral route when possible. Determine the enteral feeding tube size (e.g., small bore or large bore), insertion site (e ...

I was admitted to the hospital for a week of stabilization and education; I was given an orange, a syringe, and a vial, and was taught how to draw a dose and inject the orange. I then had to muster ...

This study provides a valuable approach to image and analyze in vivo metabolic flux through glucose turnover kinetics in glioblastoma tumor microenvironments. The evidence for the method's validity is ...